Full-Time

Director – Clinical Assay Development

Confirmed live in the last 24 hours

Alamar Biosciences

Alamar Biosciences

51-200 employees

Develops technology for protein detection and measurement

Biotechnology
Healthcare

Compensation Overview

$200k - $220kAnnually

+ Bonus + Equity

Expert

Fremont, CA, USA

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Required Skills
Data Science
Data Analysis
Requirements
  • Ph.D. or equivalent in molecular biology, biochemistry, immunology or a related field
  • 14+ years working in life science/diagnostic industry with a track record of clinical-grade immunoassay development
  • In-depth knowledge of industry standards including CLSI guidelines related to immunoassays
  • Multiplex clinical immunoassay development experience is highly desirable.
  • Hands-on experience with qPCR and/or NGS molecular assay development a plus
  • Experience in IVD product development and regulatory submissions
  • Proven leadership in building and growing technical teams
  • Strong communicator within and outside of the Company
  • Strong organizational skills and ability to adapt to shifting priorities
Responsibilities
  • Lead clinical assay development from feasibility to clinical evaluation studies according to Company design control process
  • Provide leadership and technical expertise in experimental design, execution and data analysis following CLSI guidelines
  • Ensure robust clinical performance by conducting assay optimization, stability testing, interference testing, etc.
  • Draft technical documents and reports to support regulatory submissions
  • Provide expert leadership in troubleshooting and assay optimization
  • Work closely with biostatistics/data science groups to align study designs and acceptance criteria
  • Build and manage team by coaching and fostering teamwork
  • Collaborate across company to contribute to strategic direction and ensure product meets technical and business criteria
  • Collaborate with external key opinion leaders in assay development and validation
Desired Qualifications
  • Multiplex clinical immunoassay development experience is highly desirable.
  • Hands-on experience with qPCR and/or NGS molecular assay development a plus

Alamar Biosciences focuses on the study of proteins, known as proteomics, to enhance disease detection and treatment. The company has created NULISA™, a technology that can detect and measure proteins in the human body with high sensitivity and a wide range. This allows researchers and clinicians to profile clinically relevant protein biomarkers, which are essential for developing new diagnostic tests and treatments for various diseases. Alamar's ARGO™ system complements NULISA™ by providing a fully automated, high-throughput platform for precision proteomics. Unlike competitors, Alamar's technology simplifies the process, reducing the need for extensive technical expertise, making it accessible to a broader range of clients. The goal of Alamar Biosciences is to improve our understanding of proteins in health and disease, ultimately leading to better early detection and treatment options.

Company Stage

Grant

Total Funding

$225.7M

Headquarters

Hayward, California

Founded

2018

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

6%
Simplify Jobs

Simplify's Take

What believers are saying

  • ISO 13485:2016 certification boosts Alamar's credibility in the medical device industry.
  • European expansion with Milan headquarters enhances market reach and client service.
  • $10M investment accelerates Alzheimer's diagnostics development, strengthening Alamar's market position.

What critics are saying

  • Increased competition from Olink and SomaLogic may impact Alamar's market share.
  • Scaling production in Europe and APAC could strain resources and affect quality.
  • Regulatory hurdles in new regions may delay product launches and affect revenue.

What makes Alamar Biosciences unique

  • Alamar's NULISA™ technology offers unprecedented sensitivity in protein detection.
  • The ARGO™ system automates high-throughput proteomics, reducing the need for technical expertise.
  • Alamar's focus on early disease detection sets it apart in the biotechnology field.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Company Match

401(k) Retirement Plan

Performance Bonus

Company Equity